These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1563983)

  • 21. Studies of HLA, factor B (Bf), complement C2 and C4 haplotypes in type 1 diabetic and control families from northern Sweden.
    Hägglöf B; Holmgren G; Holmlund G; Lindblom B; Olaisen B; Teisberg P
    Hum Hered; 1986; 36(4):201-12. PubMed ID: 3639057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Complement markers Bf and C4 in multiple sclerosis].
    Fauchet R; Madigand M; Gueguen-Duchesne MY; Papin J; Sabouraud O; Genetet B
    Rev Neurol (Paris); 1984; 140(6-7):422-5. PubMed ID: 6611572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bf S gene frequency in Nigerians with HIV infection.
    Uko GP; Dawkins RL; Mohammed I; Kay PH; Christiansen FT; Nasidi A; Bajani M
    Dis Markers; 1991; 9(6):333-8. PubMed ID: 1823312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of the complement allele C4AQ0 with primary Sjögren's syndrome in Japanese patients.
    Moriuchi J; Ichikawa Y; Takaya M; Shimizu H; Tsuji K; Wakisaka A; Dawkins R; Arimori S
    Arthritis Rheum; 1991 Feb; 34(2):224-7. PubMed ID: 1994921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic susceptibility to early onset pauciarticular juvenile chronic arthritis: a study of HLA and complement markers in 158 British patients.
    Hall PJ; Burman SJ; Laurent MR; Briggs DC; Venning HE; Leak AM; Bedford PA; Ansell BM
    Ann Rheum Dis; 1986 Jun; 45(6):464-74. PubMed ID: 3488035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bf and C3 complement types in rheumatoid arthritis.
    Dahlqvist SR; Beckman G; Beckman L
    Hum Hered; 1985; 35(4):240-5. PubMed ID: 3849467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in the metabolism of C4 isotypes in patients with complement activation.
    Peake PW; Pussell BA; Charlesworth JA; Gavrilovic L; Timmermans V
    Clin Exp Immunol; 1989 Oct; 78(1):49-53. PubMed ID: 2530015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complement factor B allotypes in the susceptibility and severity of coeliac disease in patients and relatives.
    da Rosa Utiyama SR; da Silva Kotze LM; de Messias Reason IT
    Int J Immunogenet; 2005 Oct; 32(5):307-14. PubMed ID: 16164698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complement C4 null alleles as a marker of gold or D-penicillamine toxicity in the treatment of rheumatoid arthritis.
    Clarkson RW; Sanders PA; Grennan DM
    Br J Rheumatol; 1992 Jan; 31(1):53-4. PubMed ID: 1730108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic variants of complement component 3 (C3) in DR4 positive and DR4 negative rheumatoid arthritis.
    Thomson W; Dyer PA; Sanders PA; Grennan DM
    Ann Rheum Dis; 1986 Apr; 45(4):269-71. PubMed ID: 3486637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bf and C4 phenotypes in patients with psoriasis.
    Wyatt RJ; Wang C; Hudson EC; Jones RM; Noah PW; Rosenberg EW
    Acta Derm Venereol Suppl (Stockh); 1989; 146():211-3. PubMed ID: 2609873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allelic variants for complement factors C3, C4, and B in acute necrotizing ulcerative gingivitis.
    Melnick SL; Go RC; Cogen RB; Roseman JM
    J Dent Res; 1988 May; 67(5):851-4. PubMed ID: 3163352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA and complement allotypes in Type 1 (insulin-dependent) diabetes.
    McCluskey J; McCann VJ; Kay PH; Zilko PJ; Christiansen FT; O'Neill GJ; Dawkins RL
    Diabetologia; 1983 Mar; 24(3):162-5. PubMed ID: 6573286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between allotypes of complement components C2, BF, C4 of HLA class III and cerebral stroke.
    Wang C; Zhao XZ; Chen SQ; Wang ZH
    J Tongji Med Univ; 1992; 12(2):90-3. PubMed ID: 1433424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA-A, B and DR antigens and properdin factor B allotypes in Caplan's syndrome.
    Darke C; Wagner MM; Nuki G; Dyer PA
    Br J Dis Chest; 1983 Jul; 77(3):235-42. PubMed ID: 6577907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Major histocompatibility complex class III (C2, C4, factor B) and C3 gene variants in patients with pulmonary tuberculosis.
    Senbagavalli P; Kumar N; Kaur G; Mehra NK; Geetha ST; Ramanathan VD
    Hum Immunol; 2011 Feb; 72(2):173-8. PubMed ID: 21093518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement C3 F and BF S allotypes are risk factors for Chagas disease cardiomyopathy.
    Messias-Reason IJ; Urbanetz L; Pereira da Cunha C
    Tissue Antigens; 2003 Oct; 62(4):308-12. PubMed ID: 12974797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis. Results of a followup study.
    van Zeben D; Hazes JM; Zwinderman AH; Cats A; Schreuder GM; D'Amaro J; Breedveld FC
    Arthritis Rheum; 1991 Jul; 34(7):822-30. PubMed ID: 2059230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic variability of the MHC class III complement proteins C2, BF, C4A and C4B in southern Brazil.
    de Messias IT; Reis A; de Almeida PT; Mauff G
    Exp Clin Immunogenet; 1994; 11(4):192-6. PubMed ID: 7857665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of classical complement pathway activation in rheumatoid arthritis: measurement of C1q-C4 complexes as novel activation products.
    Wouters D; Voskuyl AE; Molenaar ET; Dijkmans BA; Hack CE
    Arthritis Rheum; 2006 Apr; 54(4):1143-50. PubMed ID: 16572449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.